Gonadectomy-induced adrenocortical neoplasia in the domestic ferret (mustela putorius furo) and laboratory mouse

Veterinary Pathology

Volumn 43, Issue 2, 2006, Pages 97-117

  Bielinska, M ^a   Kiiveri, S ^b   Parviainen, H ^b   Mannisto, S ^b   Heikinheimo, M ^c   Wilson, D B ^a,d  

^a ST LOUIS CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF HELSINKI   (Finland)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^d WASHINGTON UNIVERSITY   (United States)

Author keywords

Adrenal tumor; Ferrets; Luteinizing hormone; Mice; Orchiectomy; Ovariectomy; Steroidogenesis

Indexed keywords

MUSTELA; MUSTELA PUTORIUS FURO;

EID: 33645019447     PISSN: 03009858     EISSN: 03009858     Source Type: Journal    
DOI: 10.1354/vp.43-2-97     Document Type: Review

References (135)

1. Anttonen M, Ketola I, Parviainen H, Pusa AK, Heikinheimo M: FOG-2 and GATA-4 are coexpressed in the mouse ovary and can modulate Müllerian- inhibiting substance expression. Biol Reprod 68:1333-1340, 2003
2. Apaja PM, Aatsinki JT, Rajaniemi HJ, Petaja-Repo UE: Expression of the mature luteinzing hormone receptor in rodent urogenital and adrenal tissues is developmentally regulated at a post-translational level. Endocrinology 146:3224-3232
3. Auchus RJ: Overview of dehydroepiandrosterone biosynthesis. Semin Reprod Med 22:281-288, 2004
4. Baum MJ: Use of the Ferret in Reproductive Endocrinology. In: Biology and Diseases of the Ferret, ed. Fox JG, 2nd ed., pp. 521-535. Lea & Febiger, Philadelphia, PA, 1998
5. Beuschlein F, Looyenga BD, Bleasdale SE, Mutch C, Bavers DL, Parlow AF, Nilson JH, Hammer GD: Activin induces X-zone apoptosis that inhibits luteinizing hormone-dependent adrenocortical tumor formation in inhibin-deficient mice. Mol Cell Biol 23:3951-3964, 2003
6. Beuschlein F, Looyenga BD, Reincke M, Hammer GD: Role of the inhibin/activin system and luteinizing hormone in adrenocortical tumorigenesis. Horm Metab Res 36:392-396, 2004
7. Beuschlein F, Mutch C, Bavers DL, Ulrich-Lai YM, Engeland WC, Keegan C, Hammer GD: Steroidogenic factor-1 is essential for compensatory adrenal growth following unilateral adrenalectomy. Endocrinology 143:3122-3135, 2002
8. Bielinska M, Genova E, Boime I, Parviainen H, Kiiveri S, Rahman N, Leppäluoto J, Heikinheimo M, Wilson DB: Nude mice as a model for gonadotropin-induced adrenocortical neoplasia. Endocrinology 146:3975-3984
9. Bielinska M, Parviainen H, Porter-Tinge SB, Kiiveri S, Genova E, Rahman N, Huhtaniemi IT, Muglia LJ, Heikinheimo M, Wilson DB: Mouse strain susceptibility to gonadectomy-induced adrenocortical tumor formation correlates with the expression of GATA-4 and luteinizing hormone receptor. Endocrinology 144:4123-4133, 2003
10. Burns KH, Agno JE, Sicinski P, Matzuk MM: Cyclin D2 and p27 are tissue-specific regulators of tumorigenesis in inhibin-α knockout mice. Mol Endocrinol 17:2053-2069, 2003
11. Burns KH, Owens GE, Ogbonna SC, Nilson JH, Matzuk MM: Expression profiling analyses of gonadotropin responses and tumor development in the absence of inhibins. Endocrinology 144: 4492-4507, 2003
12. Cipriano SC, Chen L, Burns KH, Koff A, Matzuk MM: Inhibin and p27 interact to regulate gonadal tumorigenesis. Mol Endocrinol 15:985-996, 2001
13. di Clemente N, Ghaffari S, Pepinsky RB, Pieau C, Josso N, Cate RL, Vigier B: A quantitative and interspecific test for biological activity of antimüllerian hormone: the fetal ovary aromatase assay. Development 114:721-727, 1992
14. Donovan BT, Matson C, Kilpatrick MJ: Effect of exposure to long days on the secretion of oestradiol, oestrone, progesterone, testosterone, androstenedione, cortisol and follicle-stimulating hormone in intact and spayed ferrets. J Endocrinol 99: 361-368, 1983
15. Donovan BT, ter Haar MB: Effects of luteinizing hormone releasing hormone on plasma folliclestimulating hormone and luteinizing hormone levels in the ferret. J Endocrinol 73:37-52, 1977
16. Douma S, Van Laar T, Zevenhoven J, Meuwissen R, Van Garderen E, Peeper DS: Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB. Nature 430:1034-1039, 2004
17. Drummond AE, Findlay JK, Ireland JJ: Animal models of inhibin action. Semin Reprod Med 22: 243-252, 2004
18. Eldridge JC, Lymangrover JR: Prolactin stimulates and potentiates adrenal steroid secretion in vitro. Horm Res 20:252-260, 1984
19. Feng ZM, Wu AZ, Zhang Z, Chen CL: GATA-1 and GATA-4 transactivate inhibin/activin beta-B-subunit gene transcription in testicular cells. Mol Endocrinol 14:1820-1835, 2000
20. Fidler WJ: Ovarian thecal metaplasia in adrenal glands. Am J Clin Pathol 67:318-323, 1977
21. Firth CH, Dünn TB: Tumours of the adrenal gland. IARC Sci Publ 111:595-609, 1994
22. Fluck CE, Miller WL: GATA-4 and GATA-6 modulate tissue-specific transcription of the human gene for P450cl7 by direct interaction with Spl. Mol Endocrinol 18:1144-1157, 2004
23. Fox JG, Marini RP: Diseases of the endocrine system. In: Biology and Diseases of the Ferret, ed. Fox JG, 2nd ed., pp. 291-305. Lea & Febiger, Philadelphia, PA, 1998
24. Frigeri C, Tsao J, Cordova M, Schimmer BP: A polymorphic form of steroidogenic factor-1 is associated with adrenocorticotropin resistance in Y1 mouse adrenocortical tumor cell mutants. Endocrinology 143:4031-4037, 2002
25. Fynn-Thompson E, Cheng H, Teixeira J: Inhibition of steroidogenesis in Leydig cells by Mullerianinhibiting substance. Mol Cell Endocrinol 211: 99-104, 2003
26. Gliatto JM, Alroy J, Schelling SH, Engler SJ, Dayal Y: A light microscopical, ultrastructural and immunohistochemical study of spindle-cell adrenocortical tumours of ferrets. J Comp Pathol 113: 175-183, 1995
27. Grazzini E, Boccara G, Joubert D, Trueba M, Durroux T, Guillon G, Gallo-Payet N, Chouinard L, Payet MD, Serradeil LG: Vasopressin regulates adrenal functions by acting through different vasopressin receptor subtypes. Adv Exp Med Biol 449:325-334, 1998
28. Gummow BM, Winnay JN, Hammer GD: Convergence of Wnt signaling and steroidogenic factor-1 (SF-1) on transcription of the rat inhibin alpha gene. J Biol Chem 278:26572-26579, 2003
29. Heikinheimo M, Ermolaeva M, Bielinska M, Rahman NA, Narita N, Huhtaniemi IT, Tapanainen JS, Wilson DB: Expression and hormonal regulation of transcription factors GATA-4 and GATA-6 in the mouse ovary. Endocrinol 138:3505-3514, 1997
30. Heikkila M, Peltoketo H, Leppaluoto J, Ilves M, Vuolteenaho O, Vainio S: Wnt-4 deficiency alters mouse adrenal cortex function, reducing aldosterone production. Endocrinology 143:4358-4365, 2002
31. Hillyer EV: Adrenal gland tumors in ferrets. J Am Vet Med Assoc 205:1660-1661, 1994
32. Hiroi H, Christenson LK, Strauss JF III: Regulation of transcription of the steroidogenic acute regulatory protein (StAR) gene: temporal and spatial changes in transcription factor binding and histone modification. Mol Cell Endocrinol 215: 119-126, 2004
33. Holmes RL: The adrenal glands of the ferret. J Anat 95:325-336, 1961
34. Huhtaniemi I, Rulli S, Ahtiainen P, Poutanen M: Multiple sites of tumorigenesis in transgenic mice overproducing hCG. Mol Cell Endocrinol 234: 117-126, 2005
35. Huhtaniemi I, Zhang FP, Kero J, Hamalainen T, Poutanen M: Transgenic and knockout mouse models for the study of luteinizing hormone and luteinizing hormone receptor function. Mol Cell Endocrinol 187:49-56, 2002
36. Hung HL, Lau J, Kim AY, Weiss MJ, Blobel GA: CREB-binding protein acetylates hematopoietic transcription factor GATA-1 at functionally important sites. Mol Cell Biol 19:3496-3505, 1999
37. Huseby RA, Bittner JJ: Differences in adrenal responsiveness to post-castrational alteration as evidenced by transplanted adrenal tissue. Cancer Res 11:954-961, 1951
38. Ito M, Yu R, Jameson JL: DAX-1 inhibits SF-1-mediated transactivation via a carboxyterminal domain that is deleted in adrenal hypoplasia congenita. Mol Cell Biol 17:1476-1483, 1997
39. Jabara S, Christenson LK, Wang CY, McAllister JM, Javitt NB, Dunaif A, Strauss JF III: Stromal cells of the human postmenopausal ovary display a distinctive biochemical and molecular phenotype. J Clin Endocrinol Metab 88:484-492, 2003
40. Jallageas M, Boissin J, Mas N: Differential photoperiodic control of seasonal variations in pulsatile luteinizing hormone release in long-day (ferret) and short-day (mink) mammals. J Biol Rhythms 9:217-231, 1994
41. Jeays-Ward K, Hoyle C, Brennan J, Dandonneau M, Alldus G, Capel B, Swain A: Endothelial and steroidogenic cell migration are regulated by WNT4 in the developing mammalian gonad. Development 130:3663-3670, 2003
42. Johnson DC, Crane LH: Inhibitory and stimulatory effect of oestrogens upon ovarian 17α-hydroxylase/C17, 20-lyase in immature hypophysectomized rats treated with gonadotrophin. J Endocrinol 145: 59-67, 1995
43. Kaaijk EM, Sasano H, Suzuki T, Beek JF, van Der Veen F: Distribution of steroidogenic enzymes involved in androgen synthesis in polycystic ovaries: an immunohistochemical study. Mol Hum Reprod 6:443-447, 2000
44. Kananen K, Markkula M, Mikola M, Rainio EM, McNeilly A, Huhtaniemi I: Gonadectomy permits adrenocortical tumorigenesis in mice transgenic for the mouse inhibin α-subunit promoter/simian virus 40 T-antigen fusion gene: evidence for negative autoregulation of the inhibin α-subunit gene. Mol Endocrinol 10:1667-1677, 1996
45. Keegan CE, Hammer GD: Recent insights into organogenesis of the adrenal cortex. Trends Endocrinol Metab 13:200-208, 2002
46. Keeney DS, Jenkins CM, Waterman MR: Developmentally regulated expression of adrenal 17α-hydroxylase cytochrome P450 in the mouse embryo. Endocrinology 136:4872-4879, 1995
47. Kero J, Poutanen M, Zhang FP, Rahman N, McNicol AM, Nilson JH, Keri RA, Huhtaniemi IT: Elevated luteinizing hormone induces expression of its receptor and promotes steroidogenesis in the adrenal cortex. J Clin Invest 105:633-641, 2000
48. Ketola I, Pentikainen V, Vaskivuo T, Ilvesmaki V, Herva R, Dunkel L, Tapanainen JS, Toppari J, Heikinheimo M: Expression of transcription factor GATA-4 during human testicular development and disease. J Clin Endocrinol Metab 85:3925-3931, 2000
49. Ketola I, Rahman N, Toppari J, Bielinska M, Porter-Tinge SB, Tapanainen JS, Huhtaniemi IT, Wilson DB, Heikinheimo M: Expression and regulation of transcription factors GATA-4 and GATA-6 in developing mouse testis. Endocrinology 140:1470-1480, 1999
50. Kiiveri S, Liu J, Arola J, Heikkilä P, Lehtonene E, Voutilainen R, Heikinheimo M: Transcription factors GATA-6, SF-1, and cell proliferation in human adrenocortical tumors. Mol Cell Endocrinol 233:47-56
51. Kiiveri S, Liu J, Westerholm-Ormio M, Narita N, Wilson DB, Voutilainen R, Heikinheimo M: Differential expression of GATA-4 and GATA-6 in fetal and adult mouse and human adrenal tissue. Endocrinology 143:3136-3143, 2002
52. Kiiveri S, Siltanen S, Rahman N, Bielinska M, Lehto VP, Huhtaniemi IT, Muglia LJ, Wilson DB, Heikinheimo M: Reciprocal changes in the expression of transcription factors GATA-4 and GATA-6 accompany adrenocortical tumorigenesis in mice and humans. Mol Med 5:490-501, 1999
53. Kim Y, Ma AG, Kitta K, Fitch SN, Ikeda T, Ihara Y, Simon AR, Evans T, Suzuki YJ: Anthracycline-induced suppression of GATA-4 transcription factor: implication in the regulation of cardiac myocyte apoptosis. Mol Pharmacol 63:368-377, 2003
54. Koch CA, Pacak K, Chrousos GP: The molecular pathogenesis of hereditary and sporadic adrenocortical and adrenomedullary tumors. J Clin Endocrinol Metab 87:5367-5384, 2002
55. Komatsu T, Mizusaki H, Mukai T, Ogawa H, Baba D, Shirakawa M, Hatakeyama S, Nakayama KI, Yamamoto H, Kikuchi A, Morohashi KI: SUMO-1 modification of the synergy control motif of Ad4BP/SF-l regulates synergistic transcription between Ad4BP/SF-l and Sox9. Mol Endocrinol 18:2451-2462, 2004
56. Kumar TR, Donehower LA, Bradley A, Matzuk MM: Transgenic mouse models for tumour-suppressor genes. J Intern Med 238:233-238, 1995
57. Lacroix A, Baldacchino V, Bourdeau I, Hamet P, Tremblay J: Cushing's syndrome variants secondary to aberrant hormone receptors. Trends Endocrinol Metab 15:375-382, 2004
58. Lalli E, Bardoni B, Zazopoulos E, Wurtz JM, Strom TM, Moras D, Sassone-Corsi P: A transcriptional silencing domain in DAX-1 whose mutation causes adrenal hypoplasia congenita. Mol Endocrinol 11:1950-1960, 1997
59. LaVoie HA: The role of GATA in mammalian reproduction. Exp Biol Med 228:1282-1290, 2003
60. Li X, Fox JG, Padrid PA: Neoplastic diseases in ferrets: 574 cases (1968-1997). J Am Vet Med Assoc 212:1402-1406, 1998
61. Lin SY, Morrison JR, Phillips DJ, de Kretser DM: Regulation of ovarian function by the TGF-beta superfamily and follistatin. Reproduction 126: 133-148, 2003
62. Lin Y, Liu A, Zhang S, Ruusunen T, Kreidberg JA, Peltoketo H, Drummond I, Vainio S: Induction of ureter branching as a response to Wnt-2b signaling during early kidney organogenesis. Dev Dyn 222:26-39, 2001
63. Lo KC, Lei Z, Rao C, Beck J, Lamb DJ: De novo testosterone production in luteinizing hormone receptor knockout mice after transplantation of leydig stem cells. Endocrinology 145:4011-4015, 2004
64. Magalhaes MC: A new crystal-containing cell in human adrenal cortex. J Cell Biol 55:126-133, 1972
65. Magoffin DA, Erickson GF: Direct inhibitory effect of estrogen on LH-stimulated androgen synthesis by ovarian cells cultured in defined medium. Mol Cell Endocrinology 28:81-89, 1982
66. Magoffin DA, Erickson GF: Prolactin inhibition of luteinizing hormone-stimulated androgen synthesis in ovarian interstitial cells cultured in defined medium: mechanism of action. Endocrinology 111:2001-2007, 1982
67. Mann RJ, Keri RA, Nilson JH: Consequences of elevated luteinizing hormone on diverse physiological systems: use of the LHβCTP transgenic mouse as a model of ovarian hyperstimulation-induced pathophysiology. Recent Prog Horm Res 58: 343-375, 2003
68. Manna PR, El Hefnawy T, Kero J, Huhtaniemi IT: Biphasic action of prolactin in the regulation of murine Leydig tumor cell functions. Endocrinology 142:308-318, 2001
69. Manna PR, Wang XJ, Stocco DM: Involvement of multiple transcription factors in the regulation of steroidogenic acute regulatory protein gene expression. Steroids 68:1125-1134, 2003
70. Martin LJ, Taniguchi H, Robert NM, Simard J, Tremblay JJ, Viger RS: GATA factors and the nuclear receptors SF-1/LRH-1 are key mutual partners in the regulation of the human HSD3B2 promoter. Mol Endocrinol 19:2358-2370
71. Matzuk MM, DeMayo FJ, Hadsell LA, Kumar TR: Overexpression of human chorionic gonado tropin causes multiple reproductive defects in transgenic mice. Biol Reprod 69:338-346, 2003
72. Matzuk MM, Finegold MJ, Mather JP, Krummen L, Lu H, Bradley A: Development of cancer cachexia-like syndrome and adrenal tumors in inhibin-deficient mice. Proc Natl Acad Sci USA 91:8817-8821, 1994
73. Matzuk MM, Finegold MJ, Mishina Y, Bradley A, Behringer RR: Synergistic effects of inhibins and müllerian-inhibiting substance on testicular tumorigenesis. Mol Endocrinol 9:1337-1345, 1995
74. Matzuk MM, Finegold MJ, Su JG, Hsueh AJ, Bradley A: Alpha-inhibin is a tumour-suppressor gene with gonadal specificity in mice. Nature 360: 313-319, 1992
75. Mikola M, Kero J, Nilson JH, Keri RA, Poutanen M, Huhtaniemi I: High levels of luteinizing hormone analog stimulate gonadal and adrenal tumorigenesis in mice transgenic for the mouse inhibin-α subunit promoter/Simian virus 40 T-antigen fusion gene. Oncogene 22:3269-3278, 2003
76. Morohashi K: The ontogenesis of the steroidogenic tissues. Genes Cells 2:95-106, 1997
77. Morrisey EE: GATA-6: the proliferation stops here - cell proliferation in glomerular mesangial and vascular smooth muscle cells. Circ Res 87: 638-640, 2000
78. Morrisey EE, Tang Z, Sigrist K, Lu MM, Jiang F, Ip HS, Parmacek MS: GATA6 regulates HNF4 and is required for differentiation of visceral endoderm in the mouse embryo. Genes Dev 12: 3579-3590, 1998
79. cip1 upregulation correlate with GATA-6-induced growth arrest in glomerular mesangial cells. Circ Res 87:699-704, 2000
80. Natoli TA, Alberta JA, Bortvin A, Taglienti ME, Menke DB, Loring J, Jaenisch R, Page DC, Housman DE, Kreidberg JA: Wtl functions in the development of germ cells in addition to somatic cell lineages of the testis. Dev Biol 268: 429-440, 2004
81. Newman SJ, Bergman PJ, Williams B, Scase T, Craft D: Characterization of spindle cell compenent of ferret (Mustela putorius furo) adrenal cortical neoplasms - correlation to clinical parameters and prognosis. Vet Comp Oncol 2:113-124, 2004
82. Odell WD, Parker LN: Control of adrenal androgen production. Endocr Res 10:617-630, 1984
83. Patterson MM, Rogers AB, Schrenzel MD, Marini RP, Fox JG: Alopecia attributed to neoplastic ovarian tissue in two ferrets. Comp Med 53: 213-217, 2003
84. Peterson RA, Kiupel M, Bielinska M, Kiiveri S, Heikinheimo M, Capen CC, Wilson DB: Transcription factor GATA-4 is a marker of anaplasia in adrenocortical neoplasms of the domestic ferret (Mustela putorius furo). Vet Pathol 41:446-449, 2004
85. Peterson RA, Kiupel M, Capen CC: Adrenal cortical carcinomas with myxoid differentiation in the domestic ferret (Mustela putorius furo). Vet Pathol 40:136-142, 2003
86. Pietila EM, Tuusa JT, Apaja PM, Aatsinki JT, Hakalahti AE, Rajaniemi HJ, Petaja-Repo UE: Inefficient maturation of the rat luteinizing hormone receptor: A putative way to regulate receptor numbers at the cell surface. J Biol Chem 280:26622-26629
87. Prunier C, Hocevar BA, Howe PH: Wnt signaling: physiology and pathology. Growth Fact 22: 141-150, 2004
88. Racine C, Rey R, Forest MG, Louis F, Ferre A, Huhtaniemi I, Josso N, di Clemente N: Receptors for anti-müllerian hormone on Leydig cells are responsible for its effects on steroidogenesis and cell differentiation. Proc Natl Acad Sci USA 95: 594-599, 1998
89. Rahman NA, Kananen RK, Paukku T, Mikola M, Markkula M, Hamalainen T, Huhtaniemi IT: Transgenic mouse models for gonadal tumorigenesis. Mol Cell Endocrinol 145:167-174, 1998
90. Rahman NA, Kiiveri S, Rivero-Muller A, Levallet J, Vierre S, Kero J, Wilson DB, Heikinheimo M, Huhtaniemi I: Adrenocortical tumorigenesis in transgenic mice expressing the inhibin α-subunit promoter/SV40 virus T-antigen transgene: relationship between ectopic expression of luteinizing hormone receptor and transcription factor GATA-4. Mol Endocrinol 18:2553-2569, 2004
91. Rahman NA, Kiiveri S, Siltanen S, Levallet J, Kero J, Lensu T, Wilson DB, Heikinheimo MT, Huhtaniemi IT: Adrenocortical tumorigenesis in transgenic mice: the role of luteinizing hormone receptor and transcription factors GATA-4 and GATA-6. Reprod Biol 1:5-9, 2001
92. Rilianawati., Kero J, Paukku T, Huhtaniemi I: Long-term testosterone treatment prevents gonadal and adrenal tumorigenesis of mice transgenic for the mouse inhibin-α subunit promoter/simian virus 40 T-antigen fusion gene. J Endocrinol 166:77-85, 2000
93. Rilianawati., Paukku T, Kero J, Zhang FP, Rahman N, Kananen K, Huhtaniemi I: Direct luteinizing hormone action triggers adrenocortical tumorigenesis in castrated mice transgenic for the murine inhibin α-subunit promoter/simian virus 40 T-antigen fusion gene. Mol Endocrinol 12:801-809, 1998
94. Risbridger GP, Schmitt JF, Robertson DM: Activins and inhibins in endocrine and other tumors. Endocr Rev 22:836-858, 2001
95. Robert NM, Tremblay JJ, Viger RS: Friend of GATA (FOG)-l and FOG-2 differentially repress the GATA-dependent activity of multiple gonadal promoters. Endocrinology 143:3963-3973, 2002
96. Romberger CF, Wong TW: Thecal metaplasia in the adrenal gland of a man with acquired bilateral testicular atrophy. Arch Pathol Lab Med 113: 1071-1075, 1989
97. Rosenthal KL: Adrenal gland disease in ferrets. Vet Clin North Am Small Anim Pract 27:401-418, 1997
98. Rosenthal KL: Endocrine diseases part II. In: Ferrets, Rabbits, and Rodents: Clinical Medicine and Surgery, ed. Hillyer EV and Quesenberry KE, pp. 91-98. W.B. Saunders Company, Philadephia, PA, 1997
99. Rosenthal KL, Peterson ME: Evaluation of plasma androgen and estrogen concentrations in ferrets with hyperadrenocorticism. J Am Vet Med Assoc 209:1097-1102, 1996
100. Rosenthal KL, Peterson ME, Quesenberry KE, Hillyer EV, Beeber NL, Moroff SD, Lothrop CD Jr: Hyperadrenocorticism associated with adrenocortical tumor or nodular hyperplasia of the adrenal gland in ferrets: 50 cases (1987-1991). J Am Vet Med Assoc 203:271-275, 1993
101. Rosol TJ, Yarrington JT, Latendresse J, Capen CC: Adrenal gland: structure, function, and mechanisms of toxicity. Toxicol Pathol 29:41-48, 2001
102. Rossi GP, Sacchetto A, Cesari M, Pessina AC: Interactions between endothelin-1 and the reninangiotensin-aldosterone system. Cardiovasc Res 43: 300-307, 1999
103. Rulli SB, Kuorelahti A, Karaer O, Pelliniemi LJ, Poutanen M, Huhtaniemi I: Reproductive disturbances, pituitary lactotrope adenomas, and mammary gland tumors in transgenic female mice producing high levels of human chorionic gonadotropin. Endocrinology 143:4084-4095, 2002
104. Russfield AB: Experimental endocrinopathies. Methods Achiev Exp Pathol 7:132-148, 1975
105. Ryan KD: Hormonal correlates of photoperiod-induced puberty in a reflex ovulator, the female ferret (Mustela furo). Biol Reprod 31:925-935, 1984
106. Ryan KD, Robinson SL: Prolactin or dopamine mediates the induction of puberty by long days in female ferrets. Endocrinology 125:2605-2611, 1989
107. Ryan KD, Siegel SF, Robinson SL: Influence of day length and endocrine status on luteinizing hormone secretion in intact and ovariectomized adult ferrets. Biol Reprod 33:690-697, 1985
108. Salva A, Hardy MP, Wu XF, Sottas CM, MacLaughlin DT, Donahoe PK, Lee MM: Müllerian-inhibiting substance inhibits rat Leydig cell regeneration after ethylene dimethanesulphonate ablation. Biol Reprod 70:600-607, 2004
109. Saner KJ, Suzuki T, Sasano H, Pizzey J, Ho C, Strauss JF III, Carr BR, Rainey WE: Steroid sulfotransferase (SULT2A1) gene transcription is regulated by steroidogenic factor 1 (SF1) and GATA-6 in the human adrenal. Mol Endocrinol 19:184-197, 2004
110. Schoemaker NJ, Schuurmans M, Moorman H, Lumeij JT: Correlation between age at neutering and age at onset of hyperadrenocorticism in ferrets. J Am Vet Med Assoc 216:195-197, 2000
111. Schoemaker NJ, Teerds KJ, Mol JA, Lumeij JT, Thijssen JH, Rijnberk A: The role of luteinizing hormone in the pathogenesis of hyperadrenocorticism in neutered ferrets. Mol Cell Endocrinol 197:117-125, 2002
112. Schoemaker NJ, van der Hage MH, Flik G, Lumeij JT, Rijnberk A: Morphology of the pituitary gland in ferrets (Mustela putorius furo) with hyperadrenocorticism. J Comp Pathol 130: 255-265, 2004
113. Schoemaker NJ, Wolfswinkel J, Mol JA, Voorhout G, Kik MJ, Lumeij JT, Rijnberk A: Urinary glucocorticoid excretion in the diagnosis of hyperadrenocorticism in ferrets. Dornest Anim Endocrinol 27:13-24, 2004
114. Sherr CJ, Roberts JM: CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13:1501-1512, 1999
115. Shi Y, Massague J: Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 113:685-700, 2003
116. Stocco C: In vivo and in vitro inhibition of cyp19 gene expression by prostaglandin F2αa in murine luteal cells: implication of GATA-4. Endocrinology 145:4957-4966, 2004
117. Tevosian SG, Albrecht KH, Crispino JD, Fujiwara Y, Eicher EM, Orkin SH: Gonadal differentiation, sex determination and normal Sry expression in mice require direct interaction between transcription partners GATA4 and FOG2. Development 129:4627-4634, 2002
118. Tremblay JJ, Viger RS: Transcription factor GATA-4 enhances Müllerian inhibiting substance gene transcription through a direct interaction with the nuclear receptor SF-1. Mol Endocrinol 13: 1388-1401, 1999
119. Tremblay JJ, Viger RS: GATA factors differentially activate multiple gonadal promoters through conserved GATA regulatory elements. Endocrinology 142:977-986, 2001
120. Tremblay JJ, Viger RS: Novel roles for GATA transcription factors in the regulation of steroidogenesis. J Steroid Biochem Mol Biol 85:291-298, 2003
121. Tullos HS, Kirschbaum A, Trentin JJ: Role of gonadotropic hormone in the initiation and progression of adrenal tumors in ovariectomized mice. Cancer Res 21:730-734, 1960
122. Vanttinen T, Liu J, Kuulasmaa T, Kivinen P, Voutilainen R: Expression of activin/inhibin signaling components in the human adrenal gland and the effects of activins and inhibins on adrenocortical steroidogenesis and apoptosis. J Endocrinol 178:479-489, 2003
123. Viger RS, Mertineit C, Trasler JM, Nemer M: Transcription factor GATA-4 is expressed in a sexually dimorphic pattern during mouse gonadal development and is a potent activator of the Müllerian inhibiting substance promoter. Development 125:2665-2755, 1998
124. Visser JA: AMH signaling: from receptor to target gene. Mol Cell Endocrinol 211:65-73, 2003
125. Wagner RA, Bailey EM, Schneider JF, Oliver JW: Leuprolide acetate treatment of adrenocortical disease in ferrets. J Am Vet Med Assoc 218: 1272-1274, 2001
126. Wagner RA, Piche CA, Jochle W, Oliver JW: Clinical and endocrine responses to treatment with deslorelin acetate implants in ferrets with adrenocortical disease. Am J Vet Res 66:910-914, 2005
127. Weber MM, Fottner C, Wolf E: The role of the insulin-like growth factor system in adrenocortical tumourigenesis. Eur J Clin Invest 30(Suppl 3): 69-75, 2000
128. Weiss CA, Scott MV: Clinical aspects and surgical treatment of hyperadrenocorticism in the domestic ferret: 94 cases (1994-1996). J Am Anim Hosp Assoc 33:487-493, 1997
129. Weiss CA, Williams BH, Scott JB, Scott MV: Surgical treatment and long-term outcome of ferrets with bilateral adrenal tumors or adrenal hyperplasia: 56 cases (1994-1997). J Am Vet Med Assoc 215:820-823, 1999
130. Wood JR, Nelson VL, Ho C, Jansen E, Wang CY, Urbanek M, McAllister JM, Mosselman S, Strauss JF III: The molecular phenotype of polycystic ovary syndrome (PCOS) theca cells and new candidate PCOS genes defined by microarray analysis. J Biol Chem 278:26380-26390, 2003
131. Wu X, Arumugam R, Baker SP, Lee MM: Pubertal and adult Leydig cell function in Müllerian inhibiting substance-deficient mice. Endocrinology 146:589-595, 2005
132. Yu RN, Ito M, Jameson JL: The murine Dax-1 promoter is stimulated by SF-1 (steroidogenic factor-1) and inhibited by COUP-TF (chicken ovalbumin upstream promoter-transcription factor) via a composite nuclear receptor-regulatory element. Mol Endocrinol 12:1010-1022, 1998
133. Yu RN, Ito M, Saunders TL, Camper SA, Jameson JL: Role of Ahch in gonadal development and gametogenesis. Nat Genet 20:353-357, 1998
134. Zazopoulos E, Lalli E, Stocco DM, Sassone-Corsi P: DNA binding and transcriptional repression by DAX-1 blocks steroidogenesis. Nature 390:311-315, 1997
135. Zhao L, Bakke M, Hanley NA, Majdic G, Stallings NR, Jeyasuria P, Parker KL: Tissue-specific knockouts of steroidogenic factor 1. Mol Cell Endocrinol 215:89-94, 2004